A Series C financing round produced $180 million for Deep Genomics, a startup that uses artificial intelligence to analyze genetic data, as well as discover and develop new drugs. The company plans to bring four programs into clinic in the next two years, while simultaneously boosting the company's pipeline.
The FDA has given breakthrough status designation to Biofourmis for its BiovitalsHF medical device software that is used to treat heart failure.
The FDA has given 510(k) clearance to NYU Langone Health for its Genome PACT genetic test for solid tumors.
Patty LaBelle is encouraging consumers to get their cancer screenings in an advertising campaign sponsored by the Community Oncologist Alliance and Cancer Care. The organizations spearheaded the campaign based on a study from Avalere Health that shows breast cancer screenings declined 85% and colon cancer screenings declined 75% during the pandemic when compared to the previous year.
- Page 1